AU Stock MarketDetailed Quotes

CUV Clinuvel Pharmaceuticals Ltd

Watchlist
  • 14.980
  • 0.0000.00%
20min DelayMarket Closed Jul 26 16:00 AET
750.55MMarket Cap25.35P/E (Static)

Clinuvel Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
(FY)Jun 30, 2018
(FY)Jun 30, 2017
(FY)Jun 30, 2016
(FY)Jun 30, 2015
(FY)Jun 30, 2014
Operating cash flow (direct method)
Cash income from operating activities
12.43%74.9M
71.59%66.62M
32.01%38.82M
-8.73%29.41M
35.62%32.22M
28.34%23.76M
407.41%18.51M
43.35%3.65M
34.32%2.55M
18.24%1.89M
Revenue from customers
12.77%74.88M
71.47%66.4M
32.22%38.72M
-9.10%29.29M
35.92%32.22M
32.25%23.71M
391.29%17.92M
43.35%3.65M
34.32%2.55M
18.24%1.89M
Income from government grants
-89.87%22.01K
--217.26K
----
----
----
--53.07K
----
----
----
----
Other cash income from operating activities
----
----
-18.25%99.36K
--121.54K
----
----
--588.02K
----
----
----
Cash paid
-21.49%-33.23M
-36.54%-27.35M
-23.04%-20.03M
-14.32%-16.28M
-13.57%-14.24M
-38.99%-12.54M
3.89%-9.02M
-17.19%-9.39M
0.63%-8.01M
10.80%-8.06M
Payments to suppliers for goods and services
-21.49%-33.23M
-36.54%-27.35M
-23.04%-20.03M
-14.32%-16.28M
-13.57%-14.24M
-38.99%-12.54M
3.89%-9.02M
-17.19%-9.39M
0.63%-8.01M
10.80%-8.06M
Direct interest received
995.24%2.73M
-36.31%249K
-38.59%390.97K
44.39%636.63K
51.74%440.92K
24.34%290.57K
39.46%233.68K
-52.66%167.56K
5.88%353.96K
-20.33%334.31K
Direct tax refund paid
-2,186.50%-7.48M
350.14%358.69K
-81.18%79.68K
1,100.16%423.37K
-80.81%35.28K
-4.75%183.84K
-63.88%193.01K
-8.06%534.3K
-43.19%581.11K
731.54%1.02M
Operating cash flow
-7.42%36.91M
107.00%39.87M
35.76%19.26M
-23.12%14.19M
57.83%18.46M
17.91%11.69M
296.88%9.92M
-11.20%-5.04M
5.80%-4.53M
30.23%-4.81M
Investing cash flow
Cash flow from continuing investing activities
-136.52%-1.03M
49.15%-434.44K
3.88%-854.33K
-245.02%-888.83K
-242.93%-257.62K
-11.33%-75.12K
31.18%-67.48K
-816.62%-98.05K
-211.32%-10.7K
-100.79%-3.44K
Net PPE purchase and sale
-136.52%-1.03M
49.15%-434.44K
3.88%-854.33K
-245.02%-888.83K
-242.93%-257.62K
-11.33%-75.12K
31.18%-67.48K
-816.62%-98.05K
-211.32%-10.7K
88.86%-3.44K
Cash from discontinued investing activities
Investing cash flow
-136.52%-1.03M
49.15%-434.44K
3.88%-854.33K
-245.02%-888.83K
-242.93%-257.62K
-11.33%-75.12K
31.18%-67.48K
-816.62%-98.05K
-211.32%-10.7K
-100.79%-3.44K
Financing cash flow
Cash flow from continuing financing activities
-48.97%-2.24M
-1.61%-1.5M
0.40%-1.48M
-44.17%-1.49M
-1.03M
-98.99%85.08K
3,666.67%8.39M
-96.76%222.7K
9.67%6.88M
Net issuance payments of debt
----
----
----
74.83%-18.5K
---73.51K
----
----
----
----
----
Net common stock issuance
----
----
----
----
----
----
-98.97%85.08K
3,626.65%8.3M
-96.76%222.7K
9.67%6.88M
Cash dividends paid
-60.00%-1.98M
0.00%-1.24M
-0.92%-1.24M
-27.88%-1.22M
---957.16K
----
----
----
----
----
Interest paid (cash flow from financing activities)
----
----
---44.41K
----
----
----
----
----
----
----
Net other financing activities
1.78%-263.72K
-34.06%-268.49K
17.70%-200.28K
---243.34K
----
----
----
--89.12K
----
----
Cash from discontinued financing activities
Financing cash flow
-48.97%-2.24M
-1.61%-1.5M
0.40%-1.48M
-44.17%-1.49M
---1.03M
----
-98.99%85.08K
3,666.67%8.39M
-96.76%222.7K
9.67%6.88M
Net cash flow
Beginning cash position
46.94%121.51M
23.89%82.69M
22.99%66.75M
49.92%54.27M
52.40%36.2M
71.56%23.75M
30.95%13.84M
-27.71%10.57M
16.36%14.63M
-1.18%12.57M
Current changes in cash
-11.31%33.64M
124.09%37.93M
43.29%16.93M
-31.19%11.81M
47.77%17.17M
16.95%11.62M
205.36%9.93M
175.35%3.25M
-308.62%-4.32M
1,245.93%2.07M
Effect of exchange rate changes
87.72%1.66M
189.92%884.21K
-248.07%-983.32K
-26.42%664.08K
9.00%902.48K
3,174.37%827.93K
-241.53%-26.93K
-92.81%19.03K
2,146.58%264.52K
-142.48%-12.93K
End cash Position
29.05%156.81M
46.94%121.51M
23.89%82.69M
22.99%66.75M
49.92%54.27M
52.40%36.2M
71.56%23.75M
30.95%13.84M
-27.71%10.57M
16.36%14.63M
Free cash from
-9.01%35.88M
114.25%39.44M
38.41%18.41M
-26.92%13.3M
56.64%18.2M
17.96%11.62M
291.81%9.85M
-13.06%-5.13M
5.62%-4.54M
30.49%-4.81M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019(FY)Jun 30, 2018(FY)Jun 30, 2017(FY)Jun 30, 2016(FY)Jun 30, 2015(FY)Jun 30, 2014
Operating cash flow (direct method)
Cash income from operating activities 12.43%74.9M71.59%66.62M32.01%38.82M-8.73%29.41M35.62%32.22M28.34%23.76M407.41%18.51M43.35%3.65M34.32%2.55M18.24%1.89M
Revenue from customers 12.77%74.88M71.47%66.4M32.22%38.72M-9.10%29.29M35.92%32.22M32.25%23.71M391.29%17.92M43.35%3.65M34.32%2.55M18.24%1.89M
Income from government grants -89.87%22.01K--217.26K--------------53.07K----------------
Other cash income from operating activities ---------18.25%99.36K--121.54K----------588.02K------------
Cash paid -21.49%-33.23M-36.54%-27.35M-23.04%-20.03M-14.32%-16.28M-13.57%-14.24M-38.99%-12.54M3.89%-9.02M-17.19%-9.39M0.63%-8.01M10.80%-8.06M
Payments to suppliers for goods and services -21.49%-33.23M-36.54%-27.35M-23.04%-20.03M-14.32%-16.28M-13.57%-14.24M-38.99%-12.54M3.89%-9.02M-17.19%-9.39M0.63%-8.01M10.80%-8.06M
Direct interest received 995.24%2.73M-36.31%249K-38.59%390.97K44.39%636.63K51.74%440.92K24.34%290.57K39.46%233.68K-52.66%167.56K5.88%353.96K-20.33%334.31K
Direct tax refund paid -2,186.50%-7.48M350.14%358.69K-81.18%79.68K1,100.16%423.37K-80.81%35.28K-4.75%183.84K-63.88%193.01K-8.06%534.3K-43.19%581.11K731.54%1.02M
Operating cash flow -7.42%36.91M107.00%39.87M35.76%19.26M-23.12%14.19M57.83%18.46M17.91%11.69M296.88%9.92M-11.20%-5.04M5.80%-4.53M30.23%-4.81M
Investing cash flow
Cash flow from continuing investing activities -136.52%-1.03M49.15%-434.44K3.88%-854.33K-245.02%-888.83K-242.93%-257.62K-11.33%-75.12K31.18%-67.48K-816.62%-98.05K-211.32%-10.7K-100.79%-3.44K
Net PPE purchase and sale -136.52%-1.03M49.15%-434.44K3.88%-854.33K-245.02%-888.83K-242.93%-257.62K-11.33%-75.12K31.18%-67.48K-816.62%-98.05K-211.32%-10.7K88.86%-3.44K
Cash from discontinued investing activities
Investing cash flow -136.52%-1.03M49.15%-434.44K3.88%-854.33K-245.02%-888.83K-242.93%-257.62K-11.33%-75.12K31.18%-67.48K-816.62%-98.05K-211.32%-10.7K-100.79%-3.44K
Financing cash flow
Cash flow from continuing financing activities -48.97%-2.24M-1.61%-1.5M0.40%-1.48M-44.17%-1.49M-1.03M-98.99%85.08K3,666.67%8.39M-96.76%222.7K9.67%6.88M
Net issuance payments of debt ------------74.83%-18.5K---73.51K--------------------
Net common stock issuance -------------------------98.97%85.08K3,626.65%8.3M-96.76%222.7K9.67%6.88M
Cash dividends paid -60.00%-1.98M0.00%-1.24M-0.92%-1.24M-27.88%-1.22M---957.16K--------------------
Interest paid (cash flow from financing activities) -----------44.41K----------------------------
Net other financing activities 1.78%-263.72K-34.06%-268.49K17.70%-200.28K---243.34K--------------89.12K--------
Cash from discontinued financing activities
Financing cash flow -48.97%-2.24M-1.61%-1.5M0.40%-1.48M-44.17%-1.49M---1.03M-----98.99%85.08K3,666.67%8.39M-96.76%222.7K9.67%6.88M
Net cash flow
Beginning cash position 46.94%121.51M23.89%82.69M22.99%66.75M49.92%54.27M52.40%36.2M71.56%23.75M30.95%13.84M-27.71%10.57M16.36%14.63M-1.18%12.57M
Current changes in cash -11.31%33.64M124.09%37.93M43.29%16.93M-31.19%11.81M47.77%17.17M16.95%11.62M205.36%9.93M175.35%3.25M-308.62%-4.32M1,245.93%2.07M
Effect of exchange rate changes 87.72%1.66M189.92%884.21K-248.07%-983.32K-26.42%664.08K9.00%902.48K3,174.37%827.93K-241.53%-26.93K-92.81%19.03K2,146.58%264.52K-142.48%-12.93K
End cash Position 29.05%156.81M46.94%121.51M23.89%82.69M22.99%66.75M49.92%54.27M52.40%36.2M71.56%23.75M30.95%13.84M-27.71%10.57M16.36%14.63M
Free cash from -9.01%35.88M114.25%39.44M38.41%18.41M-26.92%13.3M56.64%18.2M17.96%11.62M291.81%9.85M-13.06%-5.13M5.62%-4.54M30.49%-4.81M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg